JoVSA: Editorial

Vincentian Universities are engaged in service at so many levels and in so many ways, yet it is easy to move through our day unaware of the herculean efforts that our students and colleagues are engaged in. The Vincentian Universities seem rooted in the idea of service. For us, service is not another trend that we adopted, but rather it has always been part of our constitution. The work presented in this issue provides two direct examples of how we can better serve

Online Training of New Curators

The basic information in Reactome is provided by bench biologists who are experts on a particular pathway, the Reactome Team is always working hard to drive engagement. This engagement between experts, curators, editors and reviewers requires maintenance and improvement, and in this sense Reactome is itself a model for large biocuration projects that are driven by community engagement. 
 
This tutorial will highlight issues from the perspective of online training participants, the trainer's and the audience's. From the audience perspective the tutorial will introduce the concepts that drive the Reactome data model, cover the basic steps that a researcher would have to follow in order to breakdown a biological pathway into its "reaction-based" Reactome representation. Introduce the user to the tools that are used by authors, the "authortool" and the tools used by curators, the "curatortool" to move that data into the Reactome database. 
 
From the trainer perspective the tutorial will focus on the essential role that a clear explanation of a resource's data model plays in priming the audience for the technical aspects of biocuration. Technical challenges and online delivery methods will be discussed and examples of systems used will be presented with discussion of the negative and positive aspects. Pedagogical models for enhancing audience participation will be briefly presented. 
 
The Reactome project is a collaboration among Cold Spring Harbor Laboratory, The European Bioinformatics Institute, and The Gene Ontology Consortium to develop a curated resource of core pathways and reactions in human biology. The information in this database is authored by biological researchers with expertise in their fields, maintained by the Reactome editorial staff, and cross referenced with the sequence databases at NCBI, Ensembl and UniProt, the UCSC Genome Browser , KEGG (Gene and Compound ), ChEBI, PubMed and GO. 
 
The information is then managed by groups of curators at CSHL and EBI, peer-reviewed by other researchers and published on the web. While Reactome is targeted at human pathways, it also includes many individual biochemical reactions from non-human systems such as rat, mouse, pufferfish and zebrafish. This makes the database relevant to the many researchers who work on model organisms. All the information in Reactome is backed up by its provenance: either a literature citation or an electronic inference based on sequence similarity. 
 
Reactome is a free on-line resource, and Reactome software is open-source

Editorial Special Issue on Enhancement Algorithms, Methodologies and Technology for Spectral Sensing

The paper is an editorial issue on enhancement algorithms, methodologies and technology for spectral sensing and serves as a valuable and useful reference for researchers and technologists interested in the evolving state-of-the-art and/or the emerging science and technology base associated with spectral-based sensing and monitoring problem. This issue is particularly relevant to those seeking new and improved solutions for detecting chemical, biological, radiological and explosive threats on the land, sea, and in the air

Reactome - a knowledgebase of human biological pathways

Pathway curation is a powerful tool for systematically associating gene products with functions. Reactome (www.reactome.org) is a manually curated human pathway knowledgebase describing a wide range of biological processes in a computationally accessible manner. The core unit of the Reactome data model is the Reaction, whose instances form a network of biological interactions through entities that are consumed, produced, or act as catalysts. Entities are distinguished by their molecular identities and cellular locations. Set objects allow grouping of related entities. Curation is based on communication between expert authors and staff curators, facilitated by freely available data entry tools. Manually curated data are subjected to quality control and peer review by a second expert. Reactome data are released quarterly. At release time, electronic orthology inference performed on human data produces reaction predictions in 22 species ranging from mouse to bacteria. Cross-references to a large number of publicly available databases are attached, providing multiple entry points into the database. The Reactome Mart allows query submission and data retrieval from Reactome and across other databases. The SkyPainter tool provides visualization and statistical analysis of user supplied data, e.g. from microarray experiments. Reactome data are freely available in a number of data formats (e.g. BioPax, SBML)

Propensity score matching and persistence correction to reduce bias incomparative effectiveness: the effect of cinacalcet use on all-causemortality

Purpose: The generalisability of randomised controlled trials (RCTs) may be limited by restrictive entry criteria or by their experimental nature. Observational research can provide complementary findings but is prone to bias. Employing propensity score matching, to reduce such bias, we compared the real-life effect of cinacalcet use on all-cause mortality (ACM) with findings from the Evaluation of Cinacalcet Therapy to Lower Cardiovascular Events (EVOLVE) RCT in chronic haemodialysis patients. Methods: Incident adult haemodialysis patients receiving cinacalcet, recruited in a prospective observational cohort from 2007-2009 (AROii; n = 10,488), were matched to non-exposed patients regardless of future exposure status. The effect of treatment crossover was investigated with inverse probability of censoring weighted and lag-censored analyses. EVOLVE ACM data were analysed largely as described for the primary composite endpoint. Results: AROii patients receiving cinacalcet (n = 532) were matched to 1790 non-exposed patients. The treatment effect of cinacalcet on ACM in the main AROii analysis (hazard ratio 1.03 [95% confidence interval (CI) 0.78-1.35]) was closer to the null than for the Intention to Treat (ITT) analysis of EVOLVE (0.94 [95%CI 0.85-1.04]). Adjusting for non-persistence by 0- and 6-month lag-censoring and by inverse probability of censoring weight, the hazard ratios in AROii (0.76 [95%CI 0.51-1.15], 0.84 [95%CI 0.60-1.18] and 0.79 [95%CI 0.56-1.11], respectively) were comparable with those of EVOLVE (0.82 [95%CI 0.67-1.01], 0.83 [95%CI 0.73-0.96] and 0.87 [95%CI 0.71-1.06], respectively). Conclusions: Correcting for treatment crossover, we observed results in the 'real-life' setting of the AROii observational cohort that closely mirrored the results of the EVOLVE RCT. Persistence-corrected analyses revealed a trend towards reduced ACM in haemodialysis patients receiving cinacalcet therapy.Funding: DWreports having received research funding from Abbott,Genzyme and AstraZeneca and honoraria from Amgen,Abbott, Fresenius, Janssen, Otsuka, Shire and Vifor